April 9, 2020 10:13 AM EDT
News Briefing

Pfiz­er nabs col­orec­tal can­cer OK for Braftovi; Bris­tol My­ers, Pfiz­er pull out of re­gion­al deal with Por­to­la

ENDPOINTS

→ Ten months af­ter Ar­ray showed off the pos­i­tive BEA­CON-CRC da­ta that en­ticed Pfiz­er to write a $11.4 bil­lion buy­out check, the phar­ma gi­ant …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA will con­sol­i­date to five 'shared ser­vices of­fices,' ac­cord­ing to memo to Hill staffers

Trump’s broad tar­iffs ex­empt phar­ma — but for how long?

Chaot­ic tar­iff roll­out leaves as many ques­tions as an­swers for drug­mak­ers

Trump has tout­ed Right to Try as a life­saver. Sev­er­al gov­ern­ment staff sup­port­ing it were just let go

House and Sen­ate com­mit­tees call for brief­in­gs on health cuts from Kennedy

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times